Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» breast cancer
breast cancer
Pfizer's Ibrance improves survival in new breast cancer indication
BioSpace
Thu, 12/12/24 - 11:35 am
Pfizer
Ibrance
clinical trials
breast cancer
Lynparza boosts long-term survival in early breast cancer
Pharmaphorum
Thu, 12/12/24 - 11:29 am
AstraZeneca
breast cancer
Merck
Lynparza
BioNTech's overall survival data show promise of potential Keytruda killer in breast cancer
Fierce Biotech
Tue, 12/10/24 - 11:42 am
BioNTech
breast cancer
clinical trials
BNT327
Merck
Keytruda
Olema stock surges on Novartis deal and $250M private placement
Investing.com
Mon, 12/2/24 - 11:09 am
Olema
Novartis
breast cancer
Relief for AZ as Truqap hits the spot in prostate cancer
Pharmaphorum
Mon, 11/25/24 - 09:23 am
AstraZeneca
Truqap
breast cancer
clinical trials
Myriad signs five partnerships to study MRD testing in breast cancer
Clinical Trials Arena
Wed, 10/9/24 - 10:13 am
Myriad Genetics
MRD testing
breast cancer
Precise MRD
diagnostics
Roche CEO: breast cancer pill could enter $12 bln market if trials succeed
Reuters
Wed, 10/9/24 - 09:44 am
Roche
breast cancer
Giredestrant
clinical trials
Oncolytics targets accelerated approval for oncolytic virus therapy
Clinical Trials Arena
Tue, 10/8/24 - 09:50 am
Oncolytics
oncolytic viruses
pelareop
clinical trials
breast cancer
AstraZeneca's experimental drug disappoints in breast cancer survival trial
Reuters
Mon, 09/23/24 - 11:29 am
AstraZeneca
Daiichi Sankyo
clinical trials
breast cancer
Dato-DXd
Daiichi Sankyo launches first DTC ad for Enhertu, representing shift toward patient-centric oncology campaigns
Medical Marketing and Media
Sun, 09/22/24 - 09:46 pm
Daiichi Sankyo
AstraZeneca
breast cancer
metastatic breast cancer
Enhertu
DTC ads
Novartis heaps pressure on Lilly with broad FDA approval for Kisqali in early breast cancer
Fierce Pharma
Tue, 09/17/24 - 11:08 pm
Novartis
FDA
Eli Lilly
breast cancer
Kisqali
ESMO-2024: Enhertu to eclipse the standard of care in HER2+ breast cancer with brain metastases
Clinical Trials Arena
Tue, 09/17/24 - 11:20 am
ESMO
breast cancer
Daiichi Sankyo
Enhertu
metastatic breast cancer
clinical trials
Novartis’ breast cancer trial of Kisqali reveals 28.5% risk reduction
Clinical Trials Arena
Mon, 09/16/24 - 10:56 am
Novartis
Kisqali
breast cancer
clinical trials
Relay races toward pivotal trial as breast cancer data tee up clash with AstraZeneca's Truqap
Fierce Biotech
Mon, 09/9/24 - 11:01 am
Relay Therapeutics
breast cancer
RLY-2608
AstraZeneca
Truqap
clinical trials
Avenzo and Gilead partner for breast cancer combination regimen trial
Clinical Trials Arena
Wed, 09/4/24 - 11:39 am
Avenzo Therapeutics
Gilead Sciences
breast cancer
clinical trials
AVZO-021
Trodelvy
EU starts review of Enhertu in HER2-ultra-low breast cancer
Pharmaphorum
Mon, 08/19/24 - 09:56 am
EMA
Europe
AstraZeneca
Daiichi Sankyo
breast cancer
Enhertu
IceCure presents hat-trick of positive trial data for cryoablation device
Clinical Trials Arena
Mon, 07/22/24 - 06:45 pm
IceCure Medical
ProSense
cryoablation
breast cancer
Medtech
Exscientia pays $20M for full control of CDK7 drug, plans breast cancer combo trial
Fierce Biotech
Thu, 07/18/24 - 11:10 am
Exscientia
GT Apeiron
M&A
breast cancer
GTAEXS617
ASCO: AstraZeneca, Daiichi's Enhertu looks to make history again in HER2-ultralow breast cancer
Fierce Pharma
Sun, 06/2/24 - 02:46 pm
ASCO 2024
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
Pfizer, Arvinas Post Upbeat Data From Breast Cancer Study
NASDAQ
Thu, 05/16/24 - 09:54 pm
Pfizer
Arvinas
clinical trials
vepdegestrant
Ibrance
breast cancer
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »